Physician profile
John J Elliott
NPI 1295849248
$627.16
in general payments reported to CMS, 2019-2025
9 companies · $91.90 in 2025
The $91.90 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.13 · 2021: $98.42 · 2022: $188 · 2023: $202 · 2024: $32.57 · 2025: $91.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $152.82 | 2022-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $99.56 | 2019-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $98.65 | 2022-2025 | |
| Myriad Women'S Health, INC. | $87.89 | 2023 | |
| Abbvie INC. | $78.86 | 2021-2022 | |
| Therapeuticsmd, INC. | $48.12 | 2021-2022 | |
| Pfizer INC. | $29.93 | 2021 | |
| Merck Sharp & Dohme LLC | $19.45 | 2025 | Bridion |
| Mayne Pharma Commercial LLC | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.